Delgado-Ortega, L., Rubió, J. G., España, M. d. C. G. d., Carcedo, D., Puentes, L. C., & Alarcón, C. M. d. (2018). Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain. Farmacia Hospitalaria.

Delgado-Ortega, Laura, Jordi Ginés Rubió, María del Carmen Garcías de España, David Carcedo, Luis Cordero Puentes, and Carlota Moya de Alarcón. "Economic Impact of Olaparib On Maintenance Treatment of Patients With BRCA-mutation Positive, Platinum-sensitive Relapsing High-grade Serous Epithelial Ovarian Cancer in Spain." Farmacia Hospitalaria 2018.

Delgado-Ortega, Laura, et al. "Economic Impact of Olaparib On Maintenance Treatment of Patients With BRCA-mutation Positive, Platinum-sensitive Relapsing High-grade Serous Epithelial Ovarian Cancer in Spain." Farmacia Hospitalaria 2018.